Tivic Health Systems, Inc. (TIVC)

Market Cap	3.41M
Revenue (ttm)	516,000
Net Income (ttm)	-5.68M
Shares Out	878.34K
EPS (ttm)	-13.68
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,280
Open	3.920
Previous Close	3.800
Day's Range	3.720 - 3.920
52-Week Range	2.430 - 16.077
Beta	1.99
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2025

About TIVC

Tivic Health Systems, Inc., a health tech company, develops and commercializes bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for use in the treatment of sinus pain, pressure, and congestion. The company sells its products through online retailers and commercial distributors, as well as its own website. Its lead product candidate is Entolimod, a late-stage TLR5 agonist for use in the treatment of acute radiation syndrome. In addition, the company markets its commercial product under the ClearUP Sinus Pain Relie...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Nov 11, 2021
• Employees: 7
• Stock Exchange: NASDAQ
• Ticker Symbol: TIVC
• Website: https://tivichealth.com

Financial Performance

In 2024, Tivic Health Systems's revenue was $780,000, a decrease of -33.67% compared to the previous year's $1.18 million. Losses were -$5.66 million, -31.40% less than in 2023.